MENU
+Compare
PLSE
Stock ticker: NASDAQ
AS OF
Jan 3 closing price
Price
$19.63
Change
+$1.84 (+10.34%)
Capitalization
481.01M

PLSE Pulse Biosciences Forecast, Technical & Fundamental Analysis

a development stage company, which manufactures surgical and medical instruments

PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PLSE with price predictions
Jan 03, 2025

PLSE in upward trend: price rose above 50-day moving average on January 03, 2025

PLSE moved above its 50-day moving average on January 03, 2025 date and that indicates a change from a downward trend to an upward trend. In of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where PLSE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on PLSE as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PLSE just turned positive on January 03, 2025. Looking at past instances where PLSE's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for PLSE crossed bullishly above the 50-day moving average on January 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PLSE advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 172 cases where PLSE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PLSE moved out of overbought territory on December 02, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLSE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PLSE broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PLSE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.950) is normal, around the industry mean (23.369). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. PLSE's P/S Ratio (1000.000) is very high in comparison to the industry average of (41.065).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLSE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PLSE is expected to report earnings to rise 14.29% to -23 cents per share on March 27

Pulse Biosciences PLSE Stock Earnings Reports
Q4'24
Est.
$-0.24
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.10
Q4'23
Beat
by $0.02
The last earnings report on October 30 showed earnings per share of -20 cents, beating the estimate of -23 cents. With 136.20K shares outstanding, the current market capitalization sits at 481.01M.
A.I. Advisor
published General Information

General Information

a development stage company, which manufactures surgical and medical instruments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3957 Point Eden Way
Phone
+1 510 906-4600
Employees
61
Web
https://www.pulsebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGLAX48.721.12
+2.35%
Lord Abbett Growth Leaders A
NWHTX30.730.59
+1.96%
Nationwide Bailard Tech & Sci R6
MIEFX13.130.10
+0.77%
Matthews Emerging Markets Equity Ins
EXOSX32.120.14
+0.44%
Manning & Napier Overseas Series I
VCIEX8.090.02
+0.25%
VALIC Company I International Eqs Idx

PLSE and Stocks

Correlation & Price change

A.I.dvisor tells us that PLSE and CERS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLSE and CERS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+10.34%
CERS - PLSE
31%
Poorly correlated
+7.01%
IRMD - PLSE
31%
Poorly correlated
+1.06%
MBOT - PLSE
29%
Poorly correlated
+87.72%
CTKB - PLSE
28%
Poorly correlated
+3.96%
HBIO - PLSE
27%
Poorly correlated
+5.42%
More